Recurrence Patterns in Breast Cancer
Applied/Translational Research
Singapore Health Biomedical Congress
National Healthcare Group
31 December 2022
Review breast cancer recurrence patterns, focusing on early recurrence factors. Improved compliance to adjuvant therapy reduces recurrence risk.
Year Submitted: 2022
Published Date: 31 December 2022
Tags: Applied/Translational Research, Quantitative Research, Systematic Review
About this Content
Aims
Review breast cancer recurrence patterns, focusing on early recurrence factors.
Background
Breast cancer recurrence tied to stage, treatment completion, and tumor subtypes.
Methods
Retrospective review of 201 recurrence cases at a tertiary hospital over 10 years.
Results
39.3% recurred within 2 years; recurrence more common in hormone-negative tumors without adjuvant therapy.
Conclusion
Improved compliance to adjuvant therapy reduces recurrence risk.
Lessons Learnt
Adjuvant therapy compliance crucial in reducing recurrence and mortality for hormone-negative patients.
Additional Information
Bronze at SHBC 2022 (Young Investigator Award).
Keywords
Breast Cancer, Recurrence, Hormone Therapy, Adjuvant Therapy
Innovators' Details
Innovators' Details
Healthcare Cluster(s) | National Healthcare Group |
Organization(s) Involved | Tan Tock Seng Hospital |
Platform(s) | Singapore Health Biomedical Congress |
Healthcare Professional Group(s) | Medical |
Applicable Specialty or Discipline | Surgery, Oncology |
Project Lead(s) | Su Jun |
Project Member(s) | Tan Ern Yu |
Connect with this contributor!
Dr. Su Jun - jun_su@ttsh.com.sg
Project Attachment
C_454_TTSH_SHBC_2022_Recurrence_Patterns_in_Breast_Cancer.pdf